These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 1278717)

  • 41. Influence of viral hepatitis on the disposition of two compounds with high hepatic clearance: lidocaine and indocyanine green.
    Williams RL; Blaschke TF; Meffin PJ; Melmon KL; Rowland M
    Clin Pharmacol Ther; 1976 Sep; 20(3):290-9. PubMed ID: 954351
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antipyrine metabolism and bronchogenic carcinoma.
    Ambre J; Graeff D; Bures F; Haupt D; Deason K
    J Med; 1977; 8(1):57-70. PubMed ID: 267157
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antipyrine clearance and its correlation to routine liver function tests in patients with liver disease.
    Krausz Y; Zylber-Katz E; Levy M
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):253-7. PubMed ID: 7450926
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antipyrine clearance in congenital adrenal hyperplasia.
    Loche S; Rifkind AB; Stoner E; Conney AH; New MI
    Clin Endocrinol (Oxf); 1986 Sep; 25(3):233-9. PubMed ID: 3791665
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ibuprofen does not impair antipyrine clearance.
    Abernethy DR; Greenblatt DJ
    J Clin Pharmacol; 1983; 23(11-12):517-22. PubMed ID: 6662976
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of toremifene on antipyrine elimination in the isolated perfused rat liver.
    Webster LK; Ellis AG; Bishop JF
    Cancer Chemother Pharmacol; 1993; 31(4):319-23. PubMed ID: 8422697
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of drugs in rabbits with experimental acute renal failure.
    Van Peer A; Belpaire F; Bogaert M
    Pharmacology; 1978; 17(6):307-14. PubMed ID: 733890
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlations between cytochrome P-450 and oxidative metabolism of benzo[a]pyrene and 7-ethoxycoumarin in human liver in vitro and antipyrine elimination in vivo.
    Pelkonen O; Sotaniemi E; Tokola O; Ahokas JT
    Drug Metab Dispos; 1980; 8(4):218-22. PubMed ID: 6105054
    [TBL] [Abstract][Full Text] [Related]  

  • 49. On the regulation of antipyrine and oxazepam metabolism in man.
    Kellermann GH; Luyten-Kellermann M
    Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):287-96. PubMed ID: 461954
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma pharmacokinetics of adriamycin and antipyrine and its relation to the therapeutic and toxic effects.
    Preiss R; Matthias M; Sohr R; Brockmann B; Hüller H
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S79-88. PubMed ID: 3842695
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Normal antipyrine metabolism in patients with cholesterol cholelithiasis. Evidence that the disease is not due to generalized hepatic microsomal dysfunction.
    Hepner GW; Vesell ES
    Am J Dig Dis; 1975 Jan; 20(1):9-12. PubMed ID: 1115054
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhancement of hepatic drug metabolism by glutethimide in patients with liver disease.
    Farrell GC; Cooksley WG; Powell LW
    Eur J Clin Pharmacol; 1979 Sep; 16(2):113-7. PubMed ID: 499307
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolism.
    Farrell GC; Cooksley WG; Hart P; Powell LW
    Gastroenterology; 1978 Oct; 75(4):580-8. PubMed ID: 710827
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microsomal enzymes in patients with acute leukemia as determined by plasma half-life of antipyrine.
    Higuchi T; Nakamura T; Uchino H
    Cancer Chemother Pharmacol; 1980; 5(1):55-9. PubMed ID: 6936094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gross impairment of hepatic drug metabolism in a patient with chronic liver disease.
    Adjepon-Yamoah KK; Nimmo J; Prescott LF
    Br Med J; 1974 Nov; 4(5941):387-8. PubMed ID: 4425889
    [No Abstract]   [Full Text] [Related]  

  • 56. Paradoxical urinary excretion of D-glucaric acid in acute viral hepatitis.
    Sorrell MF; Burnett DA; Tuma DJ; Barak AJ
    Clin Pharmacol Ther; 1976 Sep; 20(3):365-8. PubMed ID: 954355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cimetidine impairs the elimination of theophylline and antipyrine.
    Roberts RK; Grice J; Wood L; Petroff V; McGuffie C
    Gastroenterology; 1981 Jul; 81(1):19-21. PubMed ID: 7239117
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of carbon tetrachloride (CCl4) induced liver damage on the volume of distribution, the elimination half-life and body clearance of antipyrine and warfarin in rabbits.
    Ladefoged O
    Acta Vet Scand; 1979; 20(3):429-37. PubMed ID: 506875
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microsomal enzymes in patients with gastric carcinoma as determined by plasma half-life of antipyrine.
    Higuchi T; Nakamura T; Uchino H
    Gan; 1978 Dec; 69(6):753-6. PubMed ID: 750270
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of ciprofloxacin on antipyrine metabolism.
    Ludwig E; Székely E; Csiba A; Graber H
    J Antimicrob Chemother; 1988 Jul; 22(1):61-7. PubMed ID: 3170391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.